HIV-Related Mistrust (or HIV Conspiracy Theories) and Willingness to Use PrEP Among Black Women in the United States

Overview

Journal AIDS Behav

Specialty Infectious Diseases

Date 2020 Apr 3

PMID 32239358

Citations 38

Authors

B O Ojikutu

N Amutah-Onukagha

T F Mahoney

C Tibbitt

S D Dale

K H Mayer

L M Bogart

Affiliations

Soon will be listed here.

Abstract

Uptake of pre-exposure prophylaxis (PrEP) among Black women living in the US is suboptimal. We sought to determine the association between HIV-related medical mistrust (or belief in HIV conspiracy theories) and willingness to use PrEP among Black women. We analyzed data from the 2016 National Survey on HIV in the Black Community (NSHBC), a nationally representative cross-sectional survey. Among NSHBC participants, 522 were women and 347 (69.0%) reported HIV risk factors. Only 14.1% were aware that PrEP exists; 30.8% reported willingness to use PrEP. HIV-related medical mistrust was reported by 60.4% of women. In multivariable analysis, controlling for income, education, marital status and health care engagement, belief in conspiracy theories was significantly associated with higher willingness to use PrEP. The HIV-Related Medical Mistrust Scale item: "there is a cure for HIV, but the government is withholding it from the poor" was independently associated with higher PrEP willingness. This finding speaks to the need for an improved understanding of the role of HIV-related medical mistrust among Black women to improve uptake of biomedical HIV prevention.

Citing Articles

Barriers to HIV Pre-Exposure Prophylaxis Use Among Women in the US: A Systematic Literature Review.

Mathurin A, Tafuto B, Lechner D Princ Pract Clin Res. 2024; 10(1).

PMID: 39175750 PMC: 11340659. DOI: 10.21801/ppcrj.2024.101.4.

Determinants of Potential HIV Vaccine Uptake Among Young Sexual Minoritized Men 17-24 Year Old.

John S, Walsh J, Doherty R, Rine S, ONeil A, Dang M J Acquir Immune Defic Syndr. 2024; 97(5):482-488.

PMID: 39171988 PMC: 11723810. DOI: 10.1097/QAI.0000000000003517.

Structural Racism and HIV Pre-exposure Prophylaxis Use in the Nationwide US: A County-Level Analysis.

Shi F, Mi T, Li X, Ning H, Li Z, Yang X J Racial Ethn Health Disparities. 2024; .

PMID: 39138800 PMC: 11822042. DOI: 10.1007/s40615-024-02127-5.

Effectiveness of a culturally tailored HIV intervention in promoting PrEP among black women who use drugs in community supervision programs in New York City: a randomized clinical trial.

Goddard-Eckrich D, McCrimmon T, Bond K, Chang M, Hunt T, Hall J Addict Sci Clin Pract. 2024; 19(1):55.

PMID: 39039560 PMC: 11264441. DOI: 10.1186/s13722-024-00488-0.

Assessing Structural Racism and Discrimination Along the Pre-exposure Prophylaxis Continuum: A Systematic Review.

Seyedroudbari S, Ghadimi F, Grady G, Uzosike O, Nkwihoreze H, Jemmott 3rd J AIDS Behav. 2024; 28(9):3001-3037.

PMID: 38851649 PMC: 11390845. DOI: 10.1007/s10461-024-04387-y.

References

Rutledge R, Madden L, Ogbuagu O, Meyer J . HIV Risk perception and eligibility for pre-exposure prophylaxis in women involved in the criminal justice system. AIDS Care. 2018; 30(10):1282-1289. PMC: 6085161. DOI: 10.1080/09540121.2018.1447079. View

Hodder S, Justman J, Hughes J, Wang J, Haley D, Adimora A . HIV acquisition among women from selected areas of the United States: a cohort study. Ann Intern Med. 2013; 158(1):10-8. PMC: 4033695. DOI: 10.7326/0003-4819-158-1-201301010-00004. View

McCree D, Sutton M, Bradley E, Harris N . Changes in the Disparity of HIV Diagnosis Rates Among Black Women - United States, 2010-2014. MMWR Morb Mortal Wkly Rep. 2017; 66(4):104-106. PMC: 5657835. DOI: 10.15585/mmwr.mm6604a3. View

Chapman Lambert C, Marrazzo J, Amico K, Mugavero M, Elopre L . PrEParing Women to Prevent HIV: An Integrated Theoretical Framework to PrEP Black Women in the United States. J Assoc Nurses AIDS Care. 2018; 29(6):835-848. PMC: 7439521. DOI: 10.1016/j.jana.2018.03.005. View

LaVeist T, Nickerson K, Bowie J . Attitudes about racism, medical mistrust, and satisfaction with care among African American and white cardiac patients. Med Care Res Rev. 2000; 57 Suppl 1:146-61. DOI: 10.1177/1077558700057001S07. View

Klonoff E, Landrine H . Do blacks believe that HIV/AIDS is a government conspiracy against them?. Prev Med. 1999; 28(5):451-7. DOI: 10.1006/pmed.1999.0463. View

Bogart L, Thorburn S . Are HIV/AIDS conspiracy beliefs a barrier to HIV prevention among African Americans?. J Acquir Immune Defic Syndr. 2005; 38(2):213-8. DOI: 10.1097/00126334-200502010-00014. View

Krakower D, Mayer K . The role of healthcare providers in the roll out of preexposure prophylaxis. Curr Opin HIV AIDS. 2015; 11(1):41-8. PMC: 4676563. DOI: 10.1097/COH.0000000000000206. View

Koren D, Nichols J, Simoncini G . HIV Pre-Exposure Prophylaxis and Women: Survey of the Knowledge, Attitudes, and Beliefs in an Urban Obstetrics/Gynecology Clinic. AIDS Patient Care STDS. 2018; 32(12):490-494. DOI: 10.1089/apc.2018.0030. View

10.

Baeten J, Donnell D, Ndase P, Mugo N, Campbell J, Wangisi J . Antiretroviral prophylaxis for HIV prevention in heterosexual men and women. N Engl J Med. 2012; 367(5):399-410. PMC: 3770474. DOI: 10.1056/NEJMoa1108524. View

11.

Wyatt G . Enhancing cultural and contextual intervention strategies to reduce HIV/AIDS among African Americans. Am J Public Health. 2009; 99(11):1941-5. PMC: 2759808. DOI: 10.2105/AJPH.2008.152181. View

12.

Ivy 3rd W, Miles I, Le B, Paz-Bailey G . Correlates of HIV infection among African American women from 20 cities in the United States. AIDS Behav. 2013; 18 Suppl 3:266-75. PMC: 5057389. DOI: 10.1007/s10461-013-0614-x. View

13.

Calabrese S, Willie T, Galvao R, Tekeste M, Dovidio J, Safon C . Current US Guidelines for Prescribing HIV Pre-exposure Prophylaxis (PrEP) Disqualify Many Women Who Are at Risk and Motivated to Use PrEP. J Acquir Immune Defic Syndr. 2019; 81(4):395-405. PMC: 6594908. DOI: 10.1097/QAI.0000000000002042. View

14.

Pringle K, Merchant R, Clark M . Is self-perceived HIV risk congruent with reported HIV risk among traditionally lower HIV risk and prevalence adult emergency department patients? Implications for HIV testing. AIDS Patient Care STDS. 2013; 27(10):573-84. PMC: 3837562. DOI: 10.1089/apc.2013.0013. View

15.

Musa D, Schulz R, Harris R, Silverman M, Thomas S . Trust in the health care system and the use of preventive health services by older black and white adults. Am J Public Health. 2008; 99(7):1293-9. PMC: 2696665. DOI: 10.2105/AJPH.2007.123927. View

16.

Marrazzo J, Ramjee G, Richardson B, Gomez K, Mgodi N, Nair G . Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med. 2015; 372(6):509-18. PMC: 4341965. DOI: 10.1056/NEJMoa1402269. View

17.

Goparaju L, Praschan N, Warren-Jeanpiere L, Experton L, Young M, Kassaye S . Stigma, Partners, Providers and Costs: Potential Barriers to PrEP Uptake among US Women. J AIDS Clin Res. 2017; 8(9). PMC: 5708581. DOI: 10.4172/2155-6113.1000730. View

18.

Halbert C, Armstrong K, Gandy Jr O, Shaker L . Racial differences in trust in health care providers. Arch Intern Med. 2006; 166(8):896-901. DOI: 10.1001/archinte.166.8.896. View

19.

Ojikutu B, Bogart L, Mayer K, Stopka T, Sullivan P, Ransome Y . Spatial Access and Willingness to Use Pre-Exposure Prophylaxis Among Black/African American Individuals in the United States: Cross-Sectional Survey. JMIR Public Health Surveill. 2019; 5(1):e12405. PMC: 6378549. DOI: 10.2196/12405. View

20.

Petroll A, Walsh J, Owczarzak J, McAuliffe T, Bogart L, Kelly J . PrEP Awareness, Familiarity, Comfort, and Prescribing Experience among US Primary Care Providers and HIV Specialists. AIDS Behav. 2016; 21(5):1256-1267. PMC: 5500978. DOI: 10.1007/s10461-016-1625-1. View